Acute Gout Flare Clinical Trials
2 recruiting trials for Acute Gout Flare. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Acute Gout Flare clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Across the trials that carry a phase, Phase 2 / Phase 3 is the largest group at 50% (1 studies); the largest phase groups are Phase 2 / Phase 3: 1, Phase 2: 1.
Research is led by Olatec Therapeutics LLC (1), Atom Therapeutics Co., Ltd (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Dapansutrile (drug, 1 trial), followed by Placebo Tablet, ABP-745 Dose A.
Track Acute Gout Flare trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
The purpose of this trial is to investigate the efficacy and safety of dapansutrile (OLT1177®) tablets in subjects with an acute gout flare.
Safety and Efficacy of ABP-745 in Participants With an Acute Gout Flare
A randomized, double-blind, international multicenter, colchicine and placebo-controlled study to evaluate the efficacy and safety of ABP-745 in subjects with acute gout. Efficacy...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Acute Gout Flare, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Acute Gout Flare, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Acute Gout Flare, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.